Karanewsky et al., “(Phosphinyloxy) acyl Amino Acid Inhibitors of Angiotensin Converting Enzyme. 2. Terminal Amino Acid Analogues of (S)-1-[6-Amino-2-[[hydroxy (4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline,” Journal of Medicinal Chemistry, vol. 33, No. 5 (1990), pp. 1459-1469. |
Smith et al., “Synthesis and Pharmacological Activity of Angiotensin Converting Enzyme Inhibitors: N-(Mercaptoacyl)-4-substituted—(S)—prolines,” Journal of Medicinal Chemistry, vol. 31, No. 4 (1988), pp. 875-885. |
Krapcho et al., “Angiotensin-Converting Enzyme Inhibitors. Mercaptan, Carboxyalkyl Dipeptide, and Phosphinic Acid Inhibitors Incorporating 4-Substituted Prolines,” Journal of Medicinal Chemistry, vol. 31, No. 6 (1988), pp. 1148-1160. |
Hock et al., “Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies”, Br. J. Pharmacol., vol. 102, pp. 769-773 (1991). |
Wirth et al., “Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies”, Br. J. Pharmacol., vol. 102, pp. 774-777 (1991). |
Pongracic et al., “A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin”, -Br. J. Clin. Pharmacol., vol. 31, pp. 287-294 (1981). |
Higgins et al., “A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers”, Chemical Abstracts, 190 114: 220805d (1991). |
Soler et al., “A Bradykinin Antagonist Modifies Antigen-Induced Airway Hyper-responsiveness and Airway Inflammation in Allergic Sheep”, Am. Rev. Respir. Dis., vol. 137, A327 (1989). |
John M. Stewart, “Hydroxyproline Analogs of Bradykinin”, Journal of Medicinal Chemistry, vol. 17, No. 5, pp. 537-539 (1974). |
J.M. Stewart, “Chemistry and Biologic Activity of Peptides Related to Bradykinin”, Handbook of Experimental Pharmacology, vol. XXV Supplement, Springler-Verlag Berlin Heidelberg (1979). |
J. Barabe et al., “New agonist and antagonist analogues of bradykinin”, Can. J. Physiol. Pharmacol., vol. 62, pp. 627-629 (1984). |
Raymond J. Vavreck et al., “Smooth Muscle Selectivity in Bradykinin Analogs with Multiple D-Amino Acid Substitutions”, Department of Biochemistry, University of Colorado School of Medicine, pp. 543-547. |
J. Rifo et al., “Bradykinin receptor antagonists used to characterize the heterogeneity of bradykinin-induced responses i rat vas deferens”, European Journal of Pharmacology, vol. 142, pp. 305-312 (1987). |
I.J. Zeitlin et al., “Mobilization of tissue kallikrein in inflammatory disease of the colon”, Wolfson Laboratories, Gastrointestinal Unit, Western General Hospital, and the Department of Clinical Surgery, University of Edinburgh, pp. 133-138, (1972). |
Kenji Suzuki et al., “Synthesis of Every Kinds of Peptide Fragments of Bradykinin”, Chem. Pharm. Bull., vol. 17, No. 8, pp. 1671-1678 (1969). |
D. Kyle et al., “Probing the Bradykinin Receptor: Mapping the Geometric Topography Using Ethers of Hydroxyproline in Novel Peptides”, J. Med. Chem., vol. 34, pp. 2649-2653 (1991). |